By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Berlex Biosciences (Acquired by Bayer AG in 2006) 

Press releases archived for reference only.
15049 San Pablo Avenue
Richmond  California  94804  U.S.A.
Phone: n/a Fax: n/a



Company News
Dr. Gabor Rubanyi Of Berlex Biosciences Joins Cardium Therapeutics, Inc. (CDTP.OB) As Chief Scientific Officer 6/1/2006 11:29:50 AM
Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration With Berlex Biosciences 1/24/2006 10:38:24 AM
Several Studies Of Betaseron(R) Support Berlex Biosciences' Scientific Leadership In Multiple Sclerosis10/19/2005 5:12:15 PM
Berlex Inc. Receives Approvable Letter From FDA On The Company's Second Oral Contraceptive Containing Drospirenone10/19/2005 5:12:14 PM
New Berlex Inc. Studies Demonstrate Efficacy Of Novel Lipoxin Analog In Laboratory Models Of Crohn's Disease10/19/2005 5:12:08 PM
Berlex Inc. Receives Approvable Letter For Bonefos(R) (Clodronate) For Adjuvant Treatment Of Breast Cancer10/19/2005 5:12:01 PM
Advanced Biotherapy, Inc.'s (ADVB) Senior Scientist Invited To Speak At Berlex Workshop10/19/2005 5:11:48 PM
Berlex Inc. And Schering AG (SHR) Release: Multiple Sclerosis: Long-Term Follow-Up Studies Underscore Proven Benefits Of Betaseron(R) Treatment10/19/2005 5:11:47 PM
Berlex Inc. (Montville, NJ) Completes Recruitment For Betaseron(R) BEYOND Study10/19/2005 5:11:39 PM
Teva Pharmaceutical Industries Limited (TEVA) Announces Approval Of Fludarabine Phosphate Injection10/19/2005 5:11:06 PM